A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

An international research collaboration led by Rutgers University-New Brunswick scientists that examined microscopic blobs of ...

The Chief Medical Officer and Director of Global Healthcare and Non-profits at Amazon Web Services, Dr Rowland Illing, has said that the immense computational capacity of the cloud, along with the ...

Clinical trials show stem cell therapies for Parkinson's disease are safe, potentially offering more effective treatment with fewer side effects.

Precise mapping of a patient’s brain can enable a wider range of treatments, writes DR ROWLAND ILLING, chief medical officer ...

When Izzy’s ‘Pops’, who had lived with Parkinson’s for more than a decade, lost his ability to write, she and her friend ...

CBS News Miami spoke to Jeff Lee, a devoted caregiver who has spent the last several years caring for his longtime partner, ...

For the third year, the Michael J. Fox Foundation organized a concert benefit at Belmont University's Fisher Center for ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

THURSDAY, April 17, 2025 (HealthDay News) -- Common medications like aspirin, ibuprofen, statins and beta blockers appear to slow the progress of Parkinson’s disease, a new study says.

Apr. 14, 2025 — A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders. The tool ...

Apr. 9, 2025 — A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new ... Apr. 7, 2025 — A study ...